These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

316 related articles for article (PubMed ID: 9306482)

  • 21. Field efficacy of zidovudine, lamivudine and single-dose nevirapine to prevent peripartum HIV transmission.
    Dabis F; Bequet L; Ekouevi DK; Viho I; Rouet F; Horo A; Sakarovitch C; Becquet R; Fassinou P; Dequae-Merchadou L; Welffens-Ekra C; Rouzioux C; Leroy V;
    AIDS; 2005 Feb; 19(3):309-18. PubMed ID: 15718842
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antiretroviral therapy (ART) for treating HIV infection in ART-eligible pregnant women.
    Sturt AS; Dokubo EK; Sint TT
    Cochrane Database Syst Rev; 2010 Mar; (3):CD008440. PubMed ID: 20238370
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The impact of zidovudine use in HIV-infected pregnant women on vertical transmission of HIV in Mississippi.
    Palmer AL; Gay H; Currier MM
    J Miss State Med Assoc; 2000 Feb; 41(2):479-83. PubMed ID: 10710894
    [TBL] [Abstract][Full Text] [Related]  

  • 24. After AIDS clinical trial 076: the changing pattern of zidovudine use during pregnancy, and the subsequent reduction in the vertical transmission of human immunodeficiency virus in a cohort of infected women and their infants. Women and Infants Transmission Study Group.
    Cooper ER; Nugent RP; Diaz C; Pitt J; Hanson C; Kalish LA; Mendez H; Zorrilla C; Hershow R; Moye J; Smeriglio V; Fowler MG
    J Infect Dis; 1996 Dec; 174(6):1207-11. PubMed ID: 8940210
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Oral zidovudine during labor to prevent perinatal HIV transmission, Bangkok: tolerance and zidovudine concentration in cord blood. Bangkok Collaborative Perinatal HIV Transmission Study Group.
    Bhadrakom C; Simonds RJ; Mei JV; Asavapiriyanont S; Sangtaweesin V; Vanprapar N; Moore KH; Young NL; Hannon WH; Mastro TD; Shaffer N
    AIDS; 2000 Mar; 14(5):509-16. PubMed ID: 10780713
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Triple antiretroviral compared with zidovudine and single-dose nevirapine prophylaxis during pregnancy and breastfeeding for prevention of mother-to-child transmission of HIV-1 (Kesho Bora study): a randomised controlled trial.
    ; de Vincenzi I
    Lancet Infect Dis; 2011 Mar; 11(3):171-80. PubMed ID: 21237718
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Rapid disease progression in HIV-1 perinatally infected children born to mothers receiving zidovudine monotherapy during pregnancy. The Italian register for HIV Infection in Children.
    AIDS; 1999 May; 13(8):927-33. PubMed ID: 10371173
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prenatal care and HIV infection.
    Lancioni C; Harwell T; Rutstein RM
    AIDS Patient Care STDS; 1999 Feb; 13(2):97-102. PubMed ID: 11362126
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Perinatal HIV infection and the effect of zidovudine therapy on transmission in rural and urban counties.
    Fiscus SA; Adimora AA; Schoenbach VJ; Lim W; McKinney R; Rupar D; Kenny J; Woods C; Wilfert C
    JAMA; 1996 May; 275(19):1483-8. PubMed ID: 8622222
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The clinical management of children perinatally exposed to HIV.
    Rodriguez EM; Diaz C; Glenn Fowler M
    Prim Care; 1997 Sep; 24(3):643-66. PubMed ID: 9271697
    [TBL] [Abstract][Full Text] [Related]  

  • 31. From the Centers for Disease Control and Prevention. Progress toward elimination of perinatal HIV infection--Michigan, 1993-2000.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2002 Feb; 51(5):93-7. PubMed ID: 11892955
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Maternal characteristics associated with antenatal, intrapartum, and neonatal zidovudine use in four US cities, 1994-1998.
    Orloff SL; Bulterys M; Vink P; Nesheim S; Abrams EJ; Schoenbaum E; Palumbo P; Steketee RW; Simonds RJ;
    J Acquir Immune Defic Syndr; 2001 Sep; 28(1):65-72. PubMed ID: 11579279
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Adherence to zidovudine for the prevention of perinatal transmission in HIV-infected pregnant women: the impact of social network factors, side effects, and perceived treatment efficacy.
    Demas PA; Thea DM; Weedon J; McWayne J; Bamji M; Lambert G; Schoenbaum EE
    Women Health; 2005; 42(1):99-115. PubMed ID: 16418124
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Highly active antiretroviral therapy versus zidovudine/nevirapine effects on early breast milk HIV type-1 Rna: a phase II randomized clinical trial.
    Chung MH; Kiarie JN; Richardson BA; Lehman DA; Overbaugh J; Kinuthia J; Njiri F; John-Stewart GC
    Antivir Ther; 2008; 13(6):799-807. PubMed ID: 18839781
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Short course zidovudine maternal treatment in HIV-1 vertical transmission: randomized controlled multicenter trial.
    Limpongsanurak S; Thaithumyanon P; Chaithongwongwatthana S; Thisyakorn U; Ruxrungtham K; Kongsin P; Tarounotai U; Chantheptaewan N; Triratwerapong T; Ubolyam S; Phanuphak P; Virutamasen P; Hanwanich M; Hawanon P; Chulasugondha P
    J Med Assoc Thai; 2001 Jun; 84 Suppl 1():S338-45. PubMed ID: 11529355
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Preventing perinatal human immunodeficiency virus transmission: factors influencing women's intentions toward zidovudine therapy.
    Sowell RL; Murdaugh CL; Addy C; Moneyham L; Tavokoli A; Misener T
    South Med J; 2001 Dec; 94(12):1177-84. PubMed ID: 11811856
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Reduction of maternal-infant transmission of human immunodeficiency virus type 1 with zidovudine treatment. Pediatric AIDS Clinical Trials Group Protocol 076 Study Group.
    Connor EM; Sperling RS; Gelber R; Kiselev P; Scott G; O'Sullivan MJ; VanDyke R; Bey M; Shearer W; Jacobson RL
    N Engl J Med; 1994 Nov; 331(18):1173-80. PubMed ID: 7935654
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Human immunodeficiency virus infection in pregnant women. The importance of recognizing the infection during pregnancy and risk factors for perinatal transmission].
    Ovalle A; Vizueta E; Casals A; Northland R; González R; Labbe E
    Rev Med Chil; 2003 Jun; 131(6):633-40. PubMed ID: 12942591
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Administration of zidovudine during late pregnancy and delivery to prevent perinatal HIV transmission--Thailand, 1996-1998.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 1998 Mar; 47(8):151-4. PubMed ID: 9518278
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mother-to-child HIV transmission in a cohort of pregnant women diagnosed by rapid HIV testing at Tijuana General Hospital, Baja California, Mexico.
    Viani RM; Ruiz-Calderon J; Lopez G; Chacón-Cruz E; Spector SA
    J Int Assoc Physicians AIDS Care (Chic); 2010; 9(2):82-6. PubMed ID: 20335496
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.